BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy.
Neurosci Lett
; 797: 137080, 2023 02 16.
Article
in En
| MEDLINE
| ID: mdl-36657633
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prodrugs
/
Receptors, Metabotropic Glutamate
/
Tauopathies
/
Alzheimer Disease
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Neurosci Lett
Year:
2023
Type:
Article
Affiliation country:
United States